Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis
Sami A. Chadi(University of Toronto), Andrew G. Renehan(Manchester Academic Health Science Centre), Neil Smart(Royal Devon & Exeter NHS Foundation Trust), Arthur Sun Myint(University of Liverpool), Rodrigo Oliva Perez(Hospital Alemão Oswaldo Cruz), Guilherme Pagin São Julião(Instituto do Câncer do Estado de São Paulo), Nigel Scott(Royal Preston Hospital), Monique Maas(The Netherlands Cancer Institute), Simon Gollins(Velindre Cancer Centre), Danielle S. Bitterman(Brigham and Women's Hospital), Mark Saunders(Manchester Academic Health Science Centre), Richard D Riley(NIHR Birmingham Biomedical Research Centre), Anders Jakobsen(University of Southern Denmark), Steven D. Wexner(Georgetown University), Lee Malcomson(NIHR Manchester Biomedical Research Centre), Angelita Habr‐Gama, Alberto Lopes(Instituto Nacional do Câncer), Emily Carter Paulson(Hospital of the University of Pennsylvania), Cheng-Wen Hsiao(Tri-Service General Hospital), F. M. Smith, I. R. Daniels(Royal Devon & Exeter NHS Foundation Trust), Geerard L. Beets(The Netherlands Cancer Institute), Ane Appelt(University of Leeds), Marcus Valadão(Instituto Nacional do Câncer), Carlos Vaccaro(Hospital Italiano de Buenos Aires), Sarah O’Dwyer(The Christie NHS Foundation Trust), Gustavo Rossi(Hospital Italiano de Buenos Aires), Chien-Liang Lai(National Defense Medical Center), M. Osborne(Royal Devon & Exeter NHS Foundation Trust), Kevin Du(NYU Langone Health), Rodrigo Otávio Araújo(Instituto Nacional de Câncer - INCA), Radhika Smith(Hospital of the University of Pennsylvania), Joie Ensor(NIHR Birmingham Biomedical Research Centre)
Cited by 188
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Minimum sample size for developing a multivariable prediction model: PART II ‐ binary and time‐to‐event outcomes
|Statistics in Medicine|2018|1.1k